Enum: G2PMolecularMechanism
The mechanism of disease derived from the available evidence, following the definitions of Backwell and Marsh (PMID:35395171). These mechanisms describe a gene-disease association rather than an individual variant, so the Sequence Ontology variant terms are recorded as close mappings rather than exact meanings.
URI: valuesets:G2PMolecularMechanism
View in BioPortal
Permissible Values
| Value |
Title |
Meaning |
Description |
Close Mappings |
| LOSS_OF_FUNCTION |
loss of function |
|
Loss-of-function variants involve a loss of the normal biological function of a protein. Often these are nonsense or frameshift mutations that introduce premature stop codons. Due to nonsense-mediated decay of the resulting mRNAs, most premature stop codons will result in no protein being produced, rather than a truncated protein. However, there are also many examples of loss-of-function variants that change the amino acid sequence and result in non-functional protein products. These mutations can cause a complete loss of function (amorphic), analogous to a protein null mutation, or only a partial loss of function (hypomorphic). May also include variants in regulatory regions. |
SO:0002054 |
| GAIN_OF_FUNCTION |
gain of function |
|
Gain-of-function variants have their phenotypic effect because the mutant protein does something different than the wild-type protein. Often, these variants cause disease by increasing protein activity (hypermorphic) or introducing a completely new function (neomorphic), but the specific molecular mechanisms underlying gain-of-function mutations can be complex. May also include variants in regulatory regions. |
SO:0002053 |
| DOMINANT_NEGATIVE |
dominant negative |
|
Dominant-negative variants involve the mutant protein directly or indirectly blocking the normal biological function of the wild-type protein (antimorphic). They can thus cause a disproportionate (>50%) loss of function, even though only half of the protein is mutated eg. heterozygous variants in COL1A1 that disrupt the triple collagen helix. |
SO:0002052 |
| UNDETERMINED_NON_LOSS_OF_FUNCTION |
undetermined non-loss-of-function |
|
Very often it is difficult to distinguish between dominant negative and gain of function, but it is clearly a non-loss-of-function mechanism (e.g. from co-expression experiments showing a damaging effect from the mutant allele). |
|
| UNDETERMINED |
undetermined |
|
Not known. |
|
Slots
Annotations
| property |
value |
| stewards |
https://www.ebi.ac.uk/gene2phenotype |
| publishers |
https://www.ebi.ac.uk/gene2phenotype |
| source |
https://www.ebi.ac.uk/gene2phenotype/about/terminology#molecular-mechanism-section |
| reference |
PMID:35395171 |
Schema Source
- from schema: https://w3id.org/valuesets
LinkML Source
name: G2PMolecularMechanism
instantiates:
- valuesets_meta:ValueSetEnumDefinition
annotations:
stewards:
tag: stewards
value: https://www.ebi.ac.uk/gene2phenotype
publishers:
tag: publishers
value: https://www.ebi.ac.uk/gene2phenotype
source:
tag: source
value: https://www.ebi.ac.uk/gene2phenotype/about/terminology#molecular-mechanism-section
reference:
tag: reference
value: PMID:35395171
description: The mechanism of disease derived from the available evidence, following
the definitions of Backwell and Marsh (PMID:35395171). These mechanisms describe
a gene-disease association rather than an individual variant, so the Sequence Ontology
variant terms are recorded as close mappings rather than exact meanings.
title: G2P Molecular Mechanism
from_schema: https://w3id.org/valuesets
contributors:
- orcid:0000-0002-6601-2165
- https://github.com/anthropics/claude-code
status: STANDARD
rank: 1000
permissible_values:
LOSS_OF_FUNCTION:
text: LOSS_OF_FUNCTION
description: Loss-of-function variants involve a loss of the normal biological
function of a protein. Often these are nonsense or frameshift mutations that
introduce premature stop codons. Due to nonsense-mediated decay of the resulting
mRNAs, most premature stop codons will result in no protein being produced,
rather than a truncated protein. However, there are also many examples of loss-of-function
variants that change the amino acid sequence and result in non-functional protein
products. These mutations can cause a complete loss of function (amorphic),
analogous to a protein null mutation, or only a partial loss of function (hypomorphic).
May also include variants in regulatory regions.
title: loss of function
aliases:
- loss_of_function_variant
close_mappings:
- SO:0002054
GAIN_OF_FUNCTION:
text: GAIN_OF_FUNCTION
description: Gain-of-function variants have their phenotypic effect because the
mutant protein does something different than the wild-type protein. Often, these
variants cause disease by increasing protein activity (hypermorphic) or introducing
a completely new function (neomorphic), but the specific molecular mechanisms
underlying gain-of-function mutations can be complex. May also include variants
in regulatory regions.
title: gain of function
aliases:
- gain_of_function_variant
close_mappings:
- SO:0002053
DOMINANT_NEGATIVE:
text: DOMINANT_NEGATIVE
description: Dominant-negative variants involve the mutant protein directly or
indirectly blocking the normal biological function of the wild-type protein
(antimorphic). They can thus cause a disproportionate (>50%) loss of function,
even though only half of the protein is mutated eg. heterozygous variants in
COL1A1 that disrupt the triple collagen helix.
title: dominant negative
aliases:
- antimorphic
- dominant_negative_variant
close_mappings:
- SO:0002052
UNDETERMINED_NON_LOSS_OF_FUNCTION:
text: UNDETERMINED_NON_LOSS_OF_FUNCTION
description: Very often it is difficult to distinguish between dominant negative
and gain of function, but it is clearly a non-loss-of-function mechanism (e.g.
from co-expression experiments showing a damaging effect from the mutant allele).
title: undetermined non-loss-of-function
aliases:
- undetermined non-loss-of-function
UNDETERMINED:
text: UNDETERMINED
description: Not known.
title: undetermined